Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹204.75Admitted-Finance B 1 ANSAL CHAMBER 1 BHIKAJI CAMA PLACE DELHI NEW DELHI 110066 SOUTH WEST DELHI DELHI 110066 UDYAM DL 08 0039218 | NEW DELHI | DELHI | 110066 | ₹204.75 | L1 | Admitted-Finance |
| 2 | L2₹1,218.53Admitted-Finance M 64 BASEMENT LAJPAT NAGAR II NEW DELHI DELHI INDIA 110024 | NEW DELHI | NEW DELHI | DELHI | 110024 | ₹1,218.53 | L2 | Admitted-Finance |
| 3 | L3₹2,320.37Admitted-Finance | ₹2,320.37 | L3 | Admitted-Finance |
| 4 | L4₹3,316.59Admitted-Finance | ₹3,316.59 | L4 | Admitted-Finance |
| 5 | L5₹11,365.99Admitted-Finance | ₹11,365.99 | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | PS PHARMACEUTICALS L4 | ALBINO LIFESCIENCES PVT LTD L2 | SMPL Life Sciences Pvt. Ltd. L3 | South End Trade Links L10 | INDEX INDIA SURGICALS AND PHARMACEUTICAL SERVICES L5 | Shiva Medical Agencies L6 | SUPREME INTERNATIONAL PHARMACEUTICALS L1 | CANBERRA PHARMA L9 | Takeda Biopharmaceuticals India Private Limited L8 | Medikon India Private Limited L7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Inj Tirzepatide 2.5 mg | 1 | PFS | - | - | - | - | - | - | - | - | - | 10,500 ₹11,025 Lowest |
| 2.00 | Inj Tirzepatide 5 mg | 2 | PFS | - | - | - | - | - | - | - | - | - | 13,125 ₹13,781.25 Lowest |
| 3.00 | Drain bag for peritoneal dialysis 3000 ml | 1 | No | - | - | - | - | - | - | - | 114.1 ₹119.8 Lowest | - | - |
| 4.00 | Inj Semaglutide 0.25 mg | 2 | Vial | 1,569.77 ₹1,648.26 | - | 982.86 ₹1,032 Lowest | 1,329.52 ₹1,396 | 4,454.59 ₹4,677.32 | 4,520 ₹4,746 | - | - | - | - |
| 5.00 | Inj Semaglutide 0.5 mg | 1 | Vial | 1,588.89 ₹1,668.33 | - | 982.86 ₹1,032 Lowest | 1,481.9 ₹1,556 | 6,370.16 ₹6,688.67 | 6,400 ₹6,720 | - | - | - | - |
| 6.00 | Inj Tislelizumab 100 mg | 2 | Vial | - | - | - | 46,553.14 ₹48,880.8 Lowest | - | - | - | 46,607.14 ₹48,937.5 | - | - |
| 7.00 | Tab Finereone 10 mg | 1 | No | - | - | - | 74.75 ₹78.49 Lowest | - | - | - | - | - | - |
| 8.00 | Tab Selexipag 200 mg | 1 | No | - | - | - | 63.9 ₹67.09 Lowest | - | - | - | - | - | - |
| 9.00 | Tab Crizotinib 250 mg | 1 | No | - | 1,160.5 ₹1,218.53 | 244.16 ₹256.37 | 1,353.68 ₹1,421.36 | - | 235.87 ₹247.66 | 195 ₹204.75 Lowest | - | - | - |
| 10.00 | Inj Recombinant Factor IX 1000 IU | 1 | Vial | - | - | - | - | - | - | - | - | 32,500 ₹34,125 Lowest | - |
Tender Value
Refer Docs
Closing Date
6 Jun 2026, 10:00 amClosed
COMMANDING OFFICER
MH TRIVANDRUM
PROCUREMENT OF MEDICINE
2026_ARMY_768822_1
200294/DGLP/ECHS/IFA/28/2026
Open Tender
Drugs and Pharmaceutical Products
Buy
30 days
MH TRIVANDRUM
AS TENDER DOCUMENT
3 documents required · 3 mandatory
₹0
Exempted
10 Jun 2026
30 May 2026
6 Jun 2026
30 May 2026
6 Jun 2026
30 May 2026
30 May 2026 - 6 Jun 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Inj Tirzepatide 2.5 mg | 1 | PFS | - | - |
| 2 | Inj Tirzepatide 5 mg | 2 | PFS | - | - |
| 3 | Drain bag for peritoneal dialysis 3000 ml | 1 | No | - | - |
| 4 | Inj Semaglutide 0.25 mg | 2 | Vial | - | - |
| 5 | Inj Semaglutide 0.5 mg | 1 | Vial | - | - |
| 6 | Inj Tislelizumab 100 mg | 2 | Vial | - | - |
| 7 | Tab Finereone 10 mg | 1 | No | - | - |
| 8 | Tab Selexipag 200 mg | 1 | No | - | - |
| 9 | Tab Crizotinib 250 mg | 1 | No | - | - |
| 10 | Inj Recombinant Factor IX 1000 IU | 1 | Vial | - | - |
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.19 MB
RFPIFA28.pdf
Tender Documents • 1.18 MB
BOQ_860970.xls
BOQ • 0.37 MB
ManufacturerQuoted.xls
Additional Documents • 0.07 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].